Published in J Control Release on October 03, 2005
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives. Pharm Res (2007) 2.08
Fusion protein linkers: property, design and functionality. Adv Drug Deliv Rev (2012) 1.67
Proinsulin-transferrin fusion protein as a novel long-acting insulin analog for the inhibition of hepatic glucose production. Diabetes (2013) 1.44
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent. Proc Natl Acad Sci U S A (2005) 1.25
Human growth hormone-transferrin fusion protein for oral delivery in hypophysectomized rats. J Control Release (2009) 1.10
Transcytosis of GCSF-transferrin across rat alveolar epithelial cell monolayers. Pharm Res (2003) 1.09
Arsenite-oxidizing and arsenate-reducing bacteria associated with arsenic-rich groundwater in Taiwan. J Contam Hydrol (2010) 1.09
Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization. Pharm Res (2006) 1.07
Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett (2003) 1.04
Oral peptide and protein delivery: unfulfilled promises? Drug Discov Today (2003) 1.04
Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase. Cancer Lett (2006) 1.02
Insertion of the designed helical linker led to increased expression of tf-based fusion proteins. Pharm Res (2008) 1.02
Recombinant arginine deiminase as a differential modulator of inducible (iNOS) and endothelial (eNOS) nitric oxide synthetase activity in cultured endothelial cells. Biochem Pharmacol (2003) 0.99
Reversible lipidization for the oral delivery of salmon calcitonin. J Control Release (2003) 0.97
Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers. Curr Opin Mol Ther (2006) 0.96
Blue light negatively regulates the sexual filamentation via the Cwc1 and Cwc2 proteins in Cryptococcus neoformans. Mol Microbiol (2005) 0.95
Reversible lipidization for the oral delivery of leu-enkephalin. J Drug Target (2006) 0.93
Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway. Biochem Pharmacol (2005) 0.92
Quantitative comparison of membrane transduction and endocytosis of oligopeptides. Biochem Biophys Res Commun (2003) 0.92
The transepithelial transport of a G-CSF-transferrin conjugate in Caco-2 cells and its myelopoietic effect in BDF1 mice. Pharm Res (2004) 0.92
Comparison of cationic and amphipathic cell penetrating peptides for siRNA delivery and efficacy. Mol Pharm (2011) 0.91
Effects of receptor binding on plasma half-life of bifunctional transferrin fusion proteins. Mol Pharm (2011) 0.89
Transferrin-oligomers as potential carriers in anticancer drug delivery. Pharm Res (2004) 0.89
Membrane transduction of oligoarginine in HeLa cells is not mediated by macropinocytosis. Mol Pharm (2006) 0.88
Effects of Lipofectamine 2000/siRNA complexes on autophagy in hepatoma cells. Mol Biotechnol (2012) 0.87
A homolog of Ste6, the a-factor transporter in Saccharomyces cerevisiae, is required for mating but not for monokaryotic fruiting in Cryptococcus neoformans. Eukaryot Cell (2005) 0.86
Reversible lipidization prolongs the pharmacological effect, plasma duration, and liver retention of octreotide. Pharm Res (2005) 0.86
Comparison of monomeric and oligomeric transferrin as potential carrier in oral delivery of protein drugs. J Control Release (2005) 0.86
Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells. Mol Pharm (2009) 0.85
Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells. J Control Release (2011) 0.84
Recombinant peptide constructs for targeted cell penetrating peptide-mediated delivery. J Control Release (2012) 0.84
Evidence that membrane transduction of oligoarginine does not require vesicle formation. Exp Cell Res (2005) 0.84
Design of an in vivo cleavable disulfide linker in recombinant fusion proteins. Biotechniques (2010) 0.83
Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells. Int J Pharm (2008) 0.83
The influence of net charge and charge distribution on cellular uptake and cytosolic localization of arginine-rich peptides. J Drug Target (2010) 0.83
Characterization of transferrin receptor-mediated endocytosis and cellular iron delivery of recombinant human serum transferrin from rice (Oryza sativa L.). BMC Biotechnol (2012) 0.82
Fatty acids as therapeutic auxiliaries for oral and parenteral formulations. Adv Drug Deliv Rev (2012) 0.81
Cryptococcus neoformans mediator protein Ssn8 negatively regulates diverse physiological processes and is required for virulence. PLoS One (2011) 0.80
Enhancement of insulin transport across primary rat alveolar epithelial cell monolayers by endogenous cellular factor(s). Pharm Res (2007) 0.80
Mass spectrometry study of a transferrin-based protein drug reveals the key role of protein aggregation for successful oral delivery. Proc Natl Acad Sci U S A (2012) 0.80
Tyrphostin A8 stimulates a novel trafficking pathway of apically endocytosed transferrin through Rab11-enriched compartments in Caco-2 cells. Am J Physiol Cell Physiol (2007) 0.79
Accumulation of transferrin in Caco-2 cells: a possible mechanism of intestinal transferrin absorption. J Control Release (2007) 0.79
MAP-mediated nuclear delivery of a cargo protein. J Drug Target (2012) 0.79
A screening for suppressor mutants reveals components involved in the blue light-inhibited sexual filamentation in Cryptococcus neoformans. Fungal Genet Biol (2008) 0.79
Fast preparation of fungal DNA for PCR screening. J Microbiol Methods (2011) 0.78
Lipidization of human interferon-alpha: a new approach toward improving the delivery of protein drugs. J Control Release (2008) 0.78
Conjugation with cationic cell-penetrating peptide increases pulmonary absorption of insulin. Mol Pharm (2009) 0.78
Effects of spermine-conjugated Bowman-Birk inhibitor (spermine-BBI) on carcinogenesis and cholesterol biosynthesis in mice. Pharm Res (2003) 0.78
Structure-activity relationship of reversibly lipidized peptides: studies of fatty acid-desmopressin conjugates. Pharm Res (2002) 0.77
Vesicle-to-cytosol transport of disulfide-linked cargo mediated by an amphipathic cell-penetrating peptide. J Drug Target (2012) 0.77
Mating differentiation in Cryptococcus neoformans is negatively regulated by the Crk1 protein kinase. Fungal Genet Biol (2010) 0.77
Pharmacokinetics of recombinant bifunctional fusion proteins. Expert Opin Drug Metab Toxicol (2012) 0.77
Phylogenetic study of two truffles, Tuber formosanum and Tuber furfuraceum, identified from Taiwan. FEMS Microbiol Lett (2009) 0.76
Reversible lipidization of somatostatin analogues for the liver targeting. Eur J Pharm Biopharm (2008) 0.76
Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers. Eur J Pharm Biopharm (2008) 0.76
Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers. Mol Pharm (2014) 0.75
Molecular and functional expression of multidrug resistance-associated protein-1 in primary cultured rat alveolar epithelial cells. J Pharm Sci (2008) 0.75